Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-23-121648

Chief Financial Officer sold 10,974 shares at $35.02 ($384,336)

  • Chief Financial Officer acquired 10,974 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Smith Hunter C Chief Financial Officer 2023-11-24 Option exercise +10,974 $6.88 $75,501 72,380 D
Smith Hunter C Chief Financial Officer 2023-11-24 Sale −10,974 $35.02 $384,336 61,406 D
Derivatives
Smith Hunter C Chief Financial Officer 2023-11-24 Option exercise · Stock Option (Right to Buy) −10,974 138,120 D
Open-market sales · 10,974 sh · avg $35.02 · $384,336
Loading xslF345X05/tm2331580-1_4seq1.xml…